Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)

v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Total business combination fair value basis adjustment to inventory $ 0 $ 0 $ 1,042 $ 0
Total stock-based compensation expense 10,907 0 33,616 4,942
Total depreciation and amortization 2,907 142 6,829 392
Cost of goods sold        
Total business combination fair value basis adjustment to inventory 0 0 1,042 0
Total stock-based compensation expense 29 0 81 0
Total depreciation and amortization 921 12 1,874 32
Research and development        
Total stock-based compensation expense 419 0 1,389 0
Total depreciation and amortization 229 113 760 328
Selling, general and administrative        
Total stock-based compensation expense 10,459 0 32,146 4,942
Total depreciation and amortization $ 1,757 $ 17 $ 4,195 $ 32